Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8669508 | The Journal of Heart and Lung Transplantation | 2018 | 9 Pages |
Abstract
Our study reveals a high frequency of infiltrating B cells around the coronary arteries of allografts with CAV, independent of DSA or AMR. These cells are enriched for innate B cells with a polyreactive profile. The findings shift the focus from conventional DSA-producing B cells to the potentially pathogenic polyreactive B cells in the development of clinical CAV.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Debanjana PhD, Carolina PhD, Baoshan MD, Kevin J. MD, MSc, Sarah B. PhD, David BS, Kortney BA, Sarah PhD, Yokarla BS, Linda MD, Michael M. MD, Yoshifumi MD, PhD, Donna MD, Rodica MD, Charles MD, Susan MD, Joren C. MD, DPhil, Emmanuel PhD,